CFH Y402H polymorphism and response to intravitreal Ranibizumab in brazilian patients with neovascular age-related macular degeneration
Objective: To investigate the association between CFH gene polymorphism and response to ranibizumab in Brazilian patients with neovascular age-related macular degeneration (AMD).Methods: 95 patients were genotyped for the CFH rs1061170 (Y402H) single nucleotide polymorphism. Patients with neovascula...
Main Authors: | Carlos Eduardo Veloso, Luciana Negrão Frota de Almeida, Márcio Bittar Nehemy |
---|---|
Format: | Article |
Language: | English |
Published: |
Colégio Brasileiro de Cirurgiões
|
Series: | Revista do Colégio Brasileiro de Cirurgiões |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912014000600386&lng=en&tlng=en |
Similar Items
-
Intravitreal Aflibercept Treatment Strategies in Routine Clinical Practice of Neovascular Age-Related Macular Degeneration in Belgium: A Retrospective Observational Study
by: Joke Ruys, et al.
Published: (2020-09-01) -
Intravitreal conbercept injection for neovascular age-related macular degeneration
by: Bing-Hui Wu, et al.
Published: (2019-02-01) -
Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
by: Sam Razavi, et al.
Published: (2021-02-01) -
Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD)
by: Nur Afiqah Mohamad, et al.
Published: (2018-08-01) -
Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
by: Umut Karaca, et al.
Published: (2012-01-01)